Table 1.
Relationship between ABAT expression and clinical characteristics.
| Clinical characteristics | Levels | Low expression | High expression | P |
|---|---|---|---|---|
| N (%) | N (%) | |||
| Age | <=60 | 101 (27.1%) | 76 (20.4%) | 0.011 |
| >60 | 85 (22.8%) | 111 (29.8%) | ||
| Gender | Female | 63 (16.8%) | 58 (15.5%) | 0.658 |
| Male | 124 (33.2%) | 129 (34.5%) | ||
| T stage | T1 | 79 (21.3%) | 104 (28%) | 0.013 |
| T2 | 49 (13.2%) | 46 (12.4%) | ||
| T3 | 52 (14%) | 28 (7.5%) | ||
| T4 | 6 (1.6%) | 7 (1.9%) | ||
| N stage | N0 | 135 (52.3%) | 119 (46.1%) | 0.626 |
| N1 | 3 (1.2%) | 1 (0.4%) | ||
| M stage | M0 | 143 (52.6%) | 125 (46%) | 0.626 |
| M1 | 3 (1.1%) | 1 (0.4%) | ||
| Pathologic stage | Stage I | 76 (21.7%) | 97 (27.7%) | 0.014 |
| Stage II | 44 (12.6%) | 43 (12.3%) | ||
| Stage III | 55 (15.7%) | 30 (8.6%) | ||
| Stage IV | 3 (0.9%) | 2 (0.6%) | ||
| Histologic grade | G1 | 19 (5.1%) | 36 (9.8%) | < 0.001 |
| G2 | 78 (21.1%) | 100 (27.1%) | ||
| G3 | 80 (21.7%) | 44 (11.9%) | ||
| G4 | 8 (2.2%) | 4 (1.1%) | ||
| AFP (ng/ml) | <=400 | 86 (30.7%) | 129 (46.1%) | < 0.001 |
| >400 | 51 (18.2%) | 14 (5%) | ||
| Child-Pugh grade | A | 107 (44.4%) | 112 (46.5%) | 0.909 |
| B | 11 (4.6%) | 10 (4.1%) | ||
| C | 0 (0%) | 1 (0.4%) | ||
| Vascular invasion | No | 97 (30.5%) | 111 (34.9%) | 0.360 |
| Yes | 58 (18.2%) | 52 (16.4%) |